Products & Services, Manufacturers & Providers
IQWIG issues opinion on ticagrelor (Brilinta, AstraZeneca) for prevention after myocardial infarction
According to the German Institute for Quality and Efficiency in Health Care (IQWIG), the added benefit was called into question by data subsequently submitted.
In an unexpected move, just before the end of 2011, ...
Improving expenditure efficiency has been, for a ver...
Your Portal Link to Mass Media Universe.
Valuable Quarterly Romanian Market Analysis.
Ask the analyst
Tailor-made advice for you